In doubly infected HeLa cells, poliovirus type 1 rapidly and completely dominates vesicular stomatitis virus (VSV) plaque-forming unit production. Poliovirus type 1 shuts off incorporation of amino acids into VSV-specific proteins within 2 hr after superinfection of cells already committed to massive synthesis of VSV proteins. However, poliovirus type 1 appears to have little, if any, direct effect upon incorporation of uridine into VSV-directed ribonucleic acid (RNA) synthesis. Poliovirus apparently interferes with VSV virion production only at the level of translation of viral messenger RNA, although it interferes with host cell macromolecular syntheses at the levels of translation and transcription. 
In doubly infected HeLa cells, poliovirus type 1 rapidly and completely dominates vesicular stomatitis virus (VSV) plaque-forming unit production. Poliovirus type 1 shuts off incorporation of amino acids into VSV-specific proteins within 2 hr after superinfection of cells already committed to massive synthesis of VSV proteins. However, poliovirus type 1 appears to have little, if any, direct effect upon incorporation of uridine into VSV-directed ribonucleic acid (RNA) synthesis. Poliovirus apparently interferes with VSV virion production only at the level of translation of viral messenger RNA, although it interferes with host cell macromolecular syntheses at the levels of translation and transcription.
Poliovirus type 1 and vesicular stomatitis virus (VSV) are both single-stranded ribonucleic acid (RNA) viruses capable of producing marked cytopathic effects in sensitive cells in tissue culture. In addition to inhibiting host RNA and protein production, these viruses substitute synthesis of their own specific proteins and RNA species to varying and distinctly different extents (1, 15, 16, 18) . The experiments reported here utilized these two viruses to analyze the nature of virus-virus interactions in doubly infected cells. This analysis of poliovirus type 1 and VSV might then be useful in an attempt to understand the nature of poliovirus-cell interactions, specifically the inhibition of host imacromolecular syntheses.
A number of investigators have examined the process of interference between poliovirus and various other viruses. McCormick and Penman (12) found no interference between nonreplicating poliovirus and mengovirus. They concluded that the "inhibiting protein" of one virus did not affect the other virus and therefore the two viruses possess initiators of translation which differ from those of host cells. Choppin and Holmes (3) reported that monkey kidney cells infected with the paramyxovirus SV5 and superinfected with poliovirus showed no inhibition of production of SV5 infective virus. The poliovirus was, however, still active in inhibiting both host cell RNA and protein synthesis. Ledinko and Melnick (11) and Ledinko (10) Kiehn and Holland (9) . The electrophoretic buffer also contained 0.1% mercaptoethanol and 0.02% thioglycolate. Radioactively labeled RNA samples were run on 2.5% acrylamide, 0.5% agarose gels, using the system of gels and buffers described by Bishop et al. (2) . The gels were fractionated and counted by the procedure described by Kiehn and Holland (9) .
RESULTS
Double infection with poliovirus type 1 Fig. 2B and 2C.) Figure 2D is the pattern in cells treated exactly as in Fig. 2C except that guanidine was not present to inhibit poliovirus. VSV proteins VP-2, VP-3, and VP-S are still present, but the majority of proteins are pohlovirus specific.
The kinetics of uridine incorporation into VSVinfected, poliovirus-infected, or doubly infected cells are shown in Fig. 3A . Actinomycin D was present in the media during the 20-min pulse label in order to shut off host RNA synthesis. VP-2, VP-3, and VP-5 refer to VSV-specific viral proteins 2, 3, and 5 (13). C, HeLa cells infected at MOI 20 with VSV were superinfected with poliovirus type 1 2 hr post VSV infection at MOI 100. Four hours after the initial (VSV) infection, the cells were pulse-labeled for 15 min with 10 ,Ci of 3H-amino acids. Guanidine (2 mM) was present in the medium throughout the experiment. D, The experiment described in C was repeated except that 2 mm guanidine was omittedfrom the medium.
There was a massive synthesis of poliovirus RNA at 3 to 4 hr post poliovirus infection which overwhelmed the contribution of VSV-specific uridine incorporation. An identical experiment done with guanidine ( Fig. 3B) showed no poliovirus incorporation of uridine. VSV incorporation was unaffected by the presence of poliovirus in doubly infected cells. The decrease in VSV RNA synthesis late in infection in the presence of poliovirus is probably a secondary effect of the earlier inhibition of VSV protein synthesis.
Polyacrylamide gel electrophoresis of the labeled RNA from these experiments was used to characterize the viral RNA species being produced. Figure 4A shows VSV-specific RNA peaks 6 hr post VSV infection in the presence of guanidine. Figure 4B shows these same VSV peaks even though poliovirus and guanidine were present for 4 hr before the labeling. VSV RNA was evident even in cells superinfected with poliovirus type 1 in the absence of guanidine (Fig. 4C} . The large peak of 35S poliovirus RNA overwhelmed the VSV peaks at 40 and 32S. However, the breadth of the base around the poliovirus 35S peak and the peaks around 18, 17, and 12S all indicate the presence of VSV RNA. These findings contrast strikingly with the rapid shutoff of VSV proteins by poliovirus.
The results presented here showing the dominance of poliovirus over VSV in doubly infected 3. Repeated determinations of amino acid incorporation rates into cells infected with VSV and poliovirus in the presence of guanidine have shown that poliovirus rapidly reduces the rate of VSV-directed protein synthesis. Qualitative electrophoretic gel analysis of the types of proteins made at these reduced rates demonstrates that the remaining polypeptide synthesis is VSV-specific (Fig. 2C) . We have also repeatedly observed that as a result of poliovirus superinfection there is a proportionally greater decrease in the height of VP-5 and VP-2 peaks relative to the core protein peak (VP-3). In the absence of guanidine, poliovirus both lowers the rate of VSV-specific protein synthesis and replaces this VSV synthesis with poliovirus-specific protein synthesis. This results in a polypeptide gel pattern dominated by poliovirus infection (Fig. 2D) , but some VSV polypeptides still remain. A difference in the location of synthesis for the core (VP-3) and membrane (VP-2, VP-5) proteins of VSV might explain the differences in the rates of inhibition by poliovirus. Petric and Prevec (14) found that the cytoplasm of pulse-labeled VSV 
